MicroRNA expression in salivary supernatant of patients with pancreatic cancer and its relationship with ZHENG

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Gao, Song ^a,b   Chen, Lian Yu ^a,b   Wang, Peng ^a,b   Liu, Lu Ming ^a,b   Chen, Zhen ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 16; MICRORNA 17; MICRORNA 181A; MICRORNA 181B; MICRORNA 196A; MICRORNA 21; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; SALIVA PROTEIN;

ADULT; AGED; ARTICLE; CHINESE MEDICINE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PANCREAS CANCER; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA ISOLATION; BIOSYNTHESIS; DIAGNOSTIC USE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PANCREATIC NEOPLASMS; PATHOLOGY;

ADULT; AGED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MICRORNAS; MIDDLE AGED; PANCREATIC NEOPLASMS; SALIVARY PROTEINS AND PEPTIDES;

EID: 84928164443     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/756347     Document Type: Article

References (41)

1. Z. Chen and P. Wang, "Clinical distribution andmolecular basis of traditional Chinese medicine ZHENG in cancer, " Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 783923, 8 pages, 2012.
2. W. Zhang, J. E. Dahlberg, and W. Tam, "MicroRNAs in tumorigenesis: a primer, "The American Journal of Pathology, vol. 171, no. 3, pp. 728-738, 2007.
3. A. Y. NikitinandD. C. Corney, "MicroRNAandovariancancer, " Histology and Histopathology, vol. 23, no. 9, pp. 1161-1169, 2008.
4. L. Zhang, S. Volinia, M. J. Birrer et al. , "Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 19, pp. 7004-7009, 2008.
5. A. Giannakakis, G. Coukos, A. Hatzigeorgiou, R. Sandaltzopoulos, and L. Zhang, "miRNA genetic alterations in human cancers, " Expert Opinion on BiologicalTherapy, vol. 7, no. 9, pp. 1375-1386, 2007.
6. N. Yang, G. Coukos, and L. Zhang, "MicroRNAepigenetic alterations in human cancer: one step forward in diagnosis and treatment, " International Journal of Cancer, vol. 122, no. 5, pp. 963-968, 2008.
7. F. J. Slack and J. B. Weidhaas, "MicroRNA in cancer prognosis, " The New England Journal ofMedicine, vol. 359, no. 25, pp. 2720-2722, 2008.
8. S. Deng, G. A. Calin, C. M. Croce, G. Coukos, and L. Zhang, "Mechanisms of microRNAderegulation in human cancer, " Cell Cycle, vol. 7, no. 17, pp. 2643-2646, 2008.
9. K. E. Resnick, H. Alder, J. P. Hagan, D. L. Richardson, C. M. Croce, and D. E. Cohn, "The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform, " Gynecologic Oncology, vol. 112, no. 1, pp. 55-59, 2009.
10. S.-L. Yu, H.-Y. Chen, G.-C. Chang et al. , "MicroRNA signature predicts survival and relapse in lung cancer, " Cancer Cell, vol. 13, no. 1, pp. 48-57, 2008.
11. J. Torrisani, B. Bournet, M. C. Du Rieu et al. , "Let-7 microRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression, " Human Gene Therapy, vol. 20, no. 8, pp. 831-844, 2009.
12. Y. Zhang, M. Li, H. Wang et al. , "Profiling of 95MicroRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis, " World Journal of Surgery, vol. 33, no. 4, pp. 698-709, 2009.
13. S. Volinia, G. A. Calin, C. G. Liu et al. , "A microRNA expression signature of human solid tumors defines cancer gene targets, " Proceeding of the National Academy of Sciences of the USA, vol. 103, no. 7, pp. 2257-2261, 2006.
14. T. Moriyama, K. Ohuchida, K. Mizumoto et al. , "MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance, " Molecular CancerTherapeutics, vol. 8, no. 5, pp. 1067-1074, 2009.
15. Y. Ma, S. Yu, W. Zhao, Z. Lu, and J. Chen, "MiR-27 a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2, " Cancer Letters, vol. 298, no. 2, pp. 150-158, 2010.
16. X. Kong, Y. Du, G. Wang et al. , "Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis, " Digestive Diseases and Sciences, vol. 56, no. 2, pp. 602-609, 2011.
17. J. Park, J. C. Henry, J. Jiang et al. , "MiR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor, " Biochemical and Biophysical Research Communications, vol. 406, no. 4, pp. 518-523, 2011.
18. M. Gironella, M. Seux, M. Xie et al. , "Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 41, pp. 16170-16175, 2007.
19. A. Li, N. Omura, S. M. Hong et al. , "Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels, " Cancer Research, vol. 70, no. 13, pp. 5226-5237, 2010.
20. F. U. Weiss, I. J. Marques, J. M. Woltering et al. , "Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer, " Gastroenterology, vol. 137, no. 6, pp. 2136-2145, 2009.
21. M. H. Zhu, C. Y. Zhao, M. Shi et al. , "Pancreatic cancer specific microRNA as serological markers, Chinese Medical Association branch pathology, " in Academic Conference Proceedings, pp. 128-213, 2010.
22. S. T. Mees, W. A. Mardin, C. Wendel et al. , "EP300-a miRNAregulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas, " International Journal of Cancer, vol. 126, no. 1, pp. 114-124, 2010.
23. Z. Chen, L. Chen, P. Wang, H. Dai, S. Gao, and K. Wang, "Tumor microenvironment varies under different TCM ZHENG models and correlates with treatment response to herbal medicine, " Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID635702, 10 pages, 2012.
24. Y. Lee and D. T. Wong, "Saliva: an emerging biofluid for early detection of diseases, " The American Journal of Dentistry, vol. 22, no. 4, pp. 241-248, 2009.
25. C. S. Lau and D. T. W. Wong, "Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro, " PLoS ONE, vol. 7, no. 3, Article ID e33037, 9 pages, 2012.
26. P. Denny, F. K. Hagen, M. Hardt et al. , "Theproteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions, " Journal of Proteome Research, vol. 7, no. 5, pp. 1994-2006, 2008.
27. N. J. Park, H. Zhou, D. Elashoff et al. , "Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection, " Clinical Cancer Research, vol. 15, no. 17, pp. 5473-5477, 2009.
28. C.-J. Liu, S.-Y. Kao, H.-F. Tu, M.-M. Tsai, K.-W. Chang, and S.-C. Lin, "Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer, " Oral Diseases, vol. 16, no. 4, pp. 360-364, 2010.
29. A. Michael, S. D. Bajracharya, P. S. T. Yuen et al. , "Exosomes from human saliva as a source of microRNA biomarkers, " Oral Diseases, vol. 16, no. 1, pp. 34-38, 2010.
30. N. Yanaihara, N. Caplen, E. Bowman et al. , "Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, " Cancer Cell, vol. 9, no. 3, pp. 189-198, 2006.
31. W. Gao, Y. Yu, H. Cao et al. , "Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis, " Biomedicine and Pharmacotherapy, vol. 64, no. 6, pp. 399-408, 2010.
32. H. J. Yan, W. S. Liu, W. H. Sun et al. , "MiR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells, " Digestive Diseases and Sciences, vol. 57, no. 12, pp. 3160-3167, 2012.
33. R. Que, G. Ding, J. Chen, and L. Cao, "Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma, " World Journal of Surgical Oncology, vol. 11, article 219, 2013.
34. M. C. Du Rieu, J. Torrisani, J. Selves et al. , "MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions, " Clinical Chemistry, vol. 56, no. 4, pp. 603-612, 2010.
35. V. S. Nair, L. S. Maeda, and J. P. A. Ioannidis, "Clinical outcome prediction by microRNAs in human cancer: a systematic review, " Journal of the National Cancer Institute, vol. 104, no. 7, pp. 528-540, 2012.
36. N. C. Panarelli, Y. T. Chen, X. K. Zhou, N. Kitabayashi, and R. K. Yantiss, "MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma, " Pancreas, vol. 41, no. 5, pp. 685-690, 2012.
37. D. Takiuchi, H. Eguchi, H. Nagano et al. , "Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells, " Pancreatology, vol. 13, no. 5, pp. 517-523, 2013.
38. L. Shi, Z. Cheng, J. Zhang et al. , "hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells, " Brain Research, vol. 1236, pp. 185-193, 2008.
39. A. Bottoni, M. C. Zatelli, M. Ferrcin et al. , "Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas, " Journal of Cellular Physiology, vol. 210, no. 2, pp. 370-377, 2007.
40. R. Visone, L. Z. Rassenti, A. Veronese et al. , "Karyotype-specific microRNA signature in chronic lymphocytic leukemia, " Blood, vol. 114, no. 18, pp. 3872-3879, 2009.
41. I. Naguibneva, M. Ameyar-Zazoua, A. Polesskaya et al. , "The microRNA miR-181 targets the homeobox proteinHox-A11 during mammalian myoblast differentiation, " Nature Cell Biology, vol. 8, no. 3, pp. 278-284, 2006.